$168.73 Nov 18, 2026 · market cap $212B
Gilead Sciences trades at $169. Our three models put it at −$11–$195 (base $195): between them. Owner earnings gives no value here, so the base is the Cash Flow model. The models disagree widely, so read the base with care.
Cash Flow $195 · Damodaran $112 · Buffett −$11 · models run Nov 18, 2026
12 of 121 tracked investors hold it · Q3 2026 13F filings
Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app